Cite

HARVARD Citation

    Leonard, M. et al. (2021). Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens. Clinical infectious diseases. pp. e2153-e2163. [Online]. 
  
Back to record